PSAT218 Technetium 99m-Methyl Diphosphonate (99mTc MDP) Radioguided Surgery in Patient With Tumor-Induced Osteomalacia (TIO)

por Khan, Sara A, Goel, Reema, Yang, Stephen, Jan de Beur, Suzanne M
Publicado 2022

OR13-1 Burosumab Improves the Biochemical, Skeletal, and Clinical Symptoms of Tumor-Induced Osteomalacia Syndrome

por Jan De Beur, Suzanne, Miller, Paul, Weber, Thomas, Peacock, Munro, Insogna, Karl, Kumar, Rajiv, Luca, Diana, Theodore-Oklota, Christina, Lampl, Kathy, San Martin, Javier, Carpenter, Thomas
Publicado 2019

OR13-1 Long-Term Burosumab Therapy Provides Sustained Benefit in Patients with Tumor-Induced Osteomalacia: End of Study Findings From the Pivotal Phase 2 Study

por Carpenter, Thomas, Cimms, Tricia, Hetzer, Joel, Insogna, Karl, Kumar, Rajiv, Merritt II, J Lawrence, Miller, Paul, Peacock, Munro, Rauch, Frank, Stanciu, Irinel, Weber, Thomas, Jan De Beur, Suzanne
Publicado 2022

Burosumab for the Treatment of Tumor‐Induced Osteomalacia

por Jan de Beur, Suzanne M, Miller, Paul D, Weber, Thomas J, Peacock, Munro, Insogna, Karl, Kumar, Rajiv, Rauch, Frank, Luca, Diana, Cimms, Tricia, Roberts, Mary Scott, San Martin, Javier, Carpenter, Thomas O
Publicado 2021

Reply to: Burosumab for Tumor‐Induced Osteomalacia: not Enough of a Good Thing

por Jan de Beur, Suzanne M., Miller, Paul D., Weber, Thomas J., Peacock, Munro, Insogna, Karl, Kumar, Rajiv, Rauch, Frank, Luca, Diana, Cimms, Tricia, Roberts, Mary Scott, Martin, Javier San, Carpenter, Thomas O.
Publicado 2021

Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

por Jan de Beur, Suzanne M., Minisola, Salvatore, Xia, Wei‐bo, Abrahamsen, Bo, Body, Jean‐Jacques, Brandi, Maria Luisa, Clifton‐Bligh, Roderick, Collins, Michael, Florenzano, Pablo, Houillier, Pascal, Imanishi, Yasuo, Imel, Erik A., Khan, Aliya A., Zillikens, M. Carola, Fukumoto, Seiji
Publicado 2022

Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristics

por Sciamanna, Christopher N., Ballentine, Noel H., Bopp, Melissa, Chinchilli, Vernon M., Ciccolo, Joseph T., Delauter, Gabrielle, Fisher, Abigail, Fox, Edward J., Jan De Beur, Suzanne M., Kearcher, Kalen, Kraschnewski, Jennifer L., Lehman, Erik, McTigue, Kathleen M., McAuley, Edward, Paranjape, Anuradha, Rodriguez-Colon, Sol, Rovniak, Liza S., Rutt, Kayla, Smyth, Joshua M., Stewart, Kerry J., Stuckey, Heather L., Tsay, Annie
Publicado 2021

Correction to: Working to increase stability through exercise (WISE): screening, recruitment, and baseline characteristics

por Sciamanna, Christopher N., Ballentine, Noel H., Bopp, Melissa, Chinchilli, Vernon M., Ciccolo, Joseph T., Delauter, Gabrielle, Fisher, Abigail, Fox, Edward J., Jan De Beur, Suzanne M., Kearcher, Kalen, Kraschnewski, Jennifer L., Lehman, Erik, McTigue, Kathleen M., McAuley, Edward, Paranjape, Anuradha, Rodriguez-Colon, Sol, Rovniak, Liza S., Rutt, Kayla, Smyth, Joshua M., Stewart, Kerry J., Stuckey, Heather L., Tsay, Annie
Publicado 2022

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

por Briot, Karine, Portale, Anthony A, Brandi, Maria Luisa, Carpenter, Thomas O, Cheong, Hae Ii, Cohen-Solal, Martine, Crowley, Rachel K, Eastell, Richard, Imanishi, Yasuo, Ing, Steven, Insogna, Karl, Ito, Nobuaki, Jan de Beur, Suzanne, Javaid, Muhammad K, Kamenicky, Peter, Keen, Richard, Kubota, Takuo, Lachmann, Robin H, Perwad, Farzana, Pitukcheewanont, Pisit, Ralston, Stuart H, Takeuchi, Yasuhiro, Tanaka, Hiroyuki, Weber, Thomas J, Yoo, Han-Wook, Nixon, Annabel, Nixon, Mark, Sun, Wei, Williams, Angela, Imel, Erik A
Publicado 2021